Concepts (51)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mandibular Diseases | 2 | 2012 | 28 | 0.530 |
Why?
|
| Fibroma | 1 | 2012 | 20 | 0.430 |
Why?
|
| Ossification, Heterotopic | 1 | 2012 | 45 | 0.420 |
Why?
|
| Nevus, Blue | 1 | 2011 | 3 | 0.380 |
Why?
|
| Palatal Neoplasms | 1 | 2011 | 10 | 0.380 |
Why?
|
| RNA, Long Noncoding | 2 | 2019 | 54 | 0.320 |
Why?
|
| Mouth Neoplasms | 2 | 2019 | 206 | 0.290 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2019 | 624 | 0.240 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2021 | 92 | 0.180 |
Why?
|
| Tongue Neoplasms | 1 | 2019 | 28 | 0.170 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 163 | 0.160 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 1140 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2019 | 447 | 0.120 |
Why?
|
| Granuloma, Giant Cell | 1 | 2012 | 1 | 0.110 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2012 | 6 | 0.110 |
Why?
|
| Mandibular Neoplasms | 1 | 2012 | 16 | 0.110 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 2012 | 10 | 0.110 |
Why?
|
| Hyperparathyroidism | 1 | 2012 | 40 | 0.110 |
Why?
|
| Sarcoma | 1 | 2012 | 70 | 0.100 |
Why?
|
| Bisphosphonate-Associated Osteonecrosis of the Jaw | 1 | 2011 | 3 | 0.100 |
Why?
|
| Maxillary Diseases | 1 | 2011 | 13 | 0.100 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2011 | 20 | 0.100 |
Why?
|
| Diphosphonates | 1 | 2011 | 39 | 0.100 |
Why?
|
| Bone Density Conservation Agents | 1 | 2011 | 43 | 0.100 |
Why?
|
| Radiography | 1 | 2012 | 572 | 0.100 |
Why?
|
| Melanocytes | 1 | 2011 | 23 | 0.090 |
Why?
|
| Melanins | 1 | 2011 | 24 | 0.090 |
Why?
|
| Imidazoles | 1 | 2011 | 175 | 0.090 |
Why?
|
| Congresses as Topic | 2 | 2019 | 85 | 0.080 |
Why?
|
| Biopsy | 1 | 2011 | 539 | 0.080 |
Why?
|
| Collagen | 1 | 2011 | 636 | 0.070 |
Why?
|
| Female | 4 | 2021 | 38021 | 0.060 |
Why?
|
| Humans | 6 | 2021 | 68549 | 0.050 |
Why?
|
| Young Adult | 1 | 2012 | 5710 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2012 | 7028 | 0.050 |
Why?
|
| Curriculum | 1 | 2021 | 575 | 0.040 |
Why?
|
| Incidence | 1 | 2021 | 1582 | 0.040 |
Why?
|
| Middle Aged | 2 | 2011 | 21119 | 0.030 |
Why?
|
| Mass Screening | 1 | 2021 | 838 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 756 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 1851 | 0.030 |
Why?
|
| Etidronic Acid | 1 | 2011 | 3 | 0.020 |
Why?
|
| Tooth Socket | 1 | 2011 | 5 | 0.020 |
Why?
|
| Alendronate | 1 | 2011 | 4 | 0.020 |
Why?
|
| Tooth Extraction | 1 | 2011 | 27 | 0.020 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2011 | 30 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 334 | 0.020 |
Why?
|
| United States | 1 | 2021 | 7338 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 3256 | 0.020 |
Why?
|
| Male | 1 | 2021 | 37283 | 0.010 |
Why?
|
| Aged | 1 | 2011 | 14842 | 0.010 |
Why?
|